Valproate Mechanism of Action
Valproate Indications
Status epilepticus that has not responded to two doses of midazolam.
Valproate Contraindications
Known severe allergy.
Valproate Cautions
None
Valproate Use in pregnancy/breastfeeding
• Valproate has been demonstrated to increase the risk of harm to the unborn baby. However, this has only been demonstrated with chronic administration
and the balance of risk is in favour of administration if the mother has status epilepticus.
• Small amounts are excreted in breast milk but the balance of risk is in favour of administration if the mother has status epilepticus.
Valproate Dose
* See the paediatric drug dose tables for a child.
Valproate Administration
Dissolve each ampoule using 4 ml of 0.9% sodium chloride. Draw up the required dose into one syringe and dilute to a total of 10-20 ml using 0.9% sodium chloride.
• Administer IV over 1-2 minutes, preferably into a running IV line.
• Do not administer IM as this causes muscle necrosis.
Valproate Common adverse effects
None
Valproate Onset of effect
• 10-20 minutes.
Valproate Duration of effect
• 6-12 hours.
Valproate Preparation
Ampoule with 400mg powder for reconstitiuion
Valproate Pharmacokinetics
• Valproate is predominantly metabolised in the liver.
• There are no significant effects from liver impairment on the initial (loading)
dose.
Valproate Common interactions
None
Valproate Additional information
• Paramedics must call for backup from an ICP if valproate is to be administered.
Valproate Sodium channel explanation
Valproate GABA explanation